Articles published in Brain Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Brain Disorders & Therapy has got h-index 12, which means every article in Brain Disorders & Therapy has got 12 average citations.

Following are the list of articles that have cited the articles published in Brain Disorders & Therapy.

  2021 2020 2019 2018 2017

Year wise published articles

46 13 13 11 16

Year wise citations received

103 84 90 74 83
Journal total citations count 713
Journal h-index 12
Important citations

Iijima M, Mitoma H, Uchiyama S, Kitagawa K. Long-term monitoring gait analysis using a wearable device in daily lives of patients with Parkinson’s disease: the efficacy of selegiline hydrochloride for gait disturbance. Frontiers in neurology. 2017;8:542.

Clark JF, Ellis JK, Burns TM, Childress JM, Divine JG. Analysis of central and peripheral vision reaction times in patients with postconcussion visual dysfunction. Clinical Journal of Sport Medicine. 2017;27:457-61.

Caltová P. Markery oxidačního stresu u Alzheimerovy choroby.

Khatlab AD. Uso de dipeptídeo de metionina sobre a morfometria, parâmetros sanguíneos e oxidativos e expressão de genes associados ao transporte de aminoácidos, sistema imune em frangos de corte desafiados por Eimeria spp.

Khatlab AD, Del Vesco AP, Neto AR, Almeida FL, Gasparino E. Dietary supplementation with free methionine or methionine dipeptide improves environment intestinal of broilers challenged with Eimeria spp. Journal of animal science. 2019.

Devi BV, Priya VV, Gayathri R. Standardization and xanthine oxidase inhibitory potential of Solanum virginianum. Drug Invention Today. 2019;11.

Jaya B, Devi RM, Saikumar P, Karthikeyan E. A comparative study of oxidative stress among gestational diabetics and normal pregnancy. National Journal of Physiology, Pharmacy and Pharmacology. 2019;9:86-9.

Kaushal N, Vohora D, Jalali RK, Jha S. Review of the Literature Examining the Association of Serum Uric Acid with Osteoporosis and Mechanistic Insights into Its Effect on Bone Metabolism. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2019;19:259-73.

Lisotto C. Gender differences in primary headaches. Reviews in Health Care. 2015;6:3-7.

Lisotto C. Differenze di genere nelle cefalee primarie. Reviews in Health Care. 2015;6:3-7.

Sowjanya K. Research and Reviews: Pharmacology and Toxicological Studies.

Wohlrab FW. Proteolytische Spaltung der Transmembranproteine PTPRN2, PLXDC2 und ENPP5 durch die Alzheimer-Protease BACE1 (Doctoral dissertation, Technische Universität München).

Zhou SL, Tan CC, Hou XH, Cao XP, Tan L, Yu JT. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease. 2019:1-4.

Elder GA, Ehrlich ME, Gandy S. Relationship of traumatic brain injury to chronic mental health problems and dementia in military veterans. Neuroscience letters. 2019:134294.

Nevado-Holgado AJ, Ribe E, Thei L, Furlong L, Mayer MA, Quan J, Richardson JC, Cavanagh J, Lovestone S, Nima Consortium. Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer’s Disease Therapeutic Development. Cells. 2019;8:425.

Phillips AE. TREM2 and Complement in Microglia; Implications for Neurodegeneration (Doctoral dissertation, UCL (University College London)).

Wu QJ, Sun SY, Yan CJ, Cheng ZC, Yang MF, Li ZF, et al. EXOC3L2 rs597668 variant contributes to Alzheimer’s disease susceptibility in Asian population. Oncotarget. 2017 ;8:20086.

Szatmari B, Balicza P, Nemeth G, Molnar MJ. The Panomics Approach in Neurodegenerative Disorders. Current medicinal chemistry. 2019.

Lord J, Cruchaga C. Caspase-8, association with Alzheimer's disease and functional analysis of rare variants.

Brookes KJ, Morgan K. Genetics of Alzheimer's Disease.